Hemosol B0

Hemosol B0 is a sterile dialysis solution formulated with calcium, lactic acid, magnesium, sodium, chloride ion, and hydrogen carbonate. It is supplied as a solution for injection intended for use in hemodialysis circuits. The product is manufactured for the European market and is classified as a renal replacement therapy solution that helps maintain electrolyte and acid‑base balance during extracorporeal blood treatment and overall patient safety.

Hemosol B0 is indicated for use in clinical settings where hemodialysis or other forms of renal replacement therapy are required.

- Provides electrolyte replacement during standard hemodialysis sessions. - Supports acid‑base regulation in patients with chronic kidney disease undergoing dialysis. - Can be used as a dialysate component in continuous renal replacement therapy (CRRT). - Suitable for use in both adult and pediatric dialysis protocols when appropriate concentration adjustments are made. - Facilitates maintenance of calcium and magnesium balance during high‑flux dialysis procedures.

Adverse events associated with Hemosol B0 are generally related to its electrolyte composition and are reported in clinical practice.

Common: - Mild transient hypotension during dialysis, often self‑limiting and managed by adjusting ultrafiltration. - Slight rise in serum calcium or magnesium that usually normalizes without additional therapy. - Minor discomfort at the vascular access site, alleviated by standard catheter care.

Serious: - Severe hypercalcemia that may cause cardiac arrhythmia and requires prompt medical intervention. - Acute metabolic alkalosis from excess buffering agents, possibly needing dialysate composition adjustment. - Anaphylactic or severe hypersensitivity reaction to solution components, demanding immediate emergency treatment.

When using Hemosol B0, clinicians should observe specific precautions to ensure patient safety and optimal dialysis performance.

- Verify patient electrolyte baseline values before initiating treatment to avoid over‑correction. - Adjust calcium and magnesium concentrations for patients with known cardiac or neuromuscular disorders. - Monitor acid‑base status regularly during therapy, especially in patients prone to metabolic alkalosis. - Use compatible infusion sets and tubing to prevent precipitation of calcium salts. - Ensure proper storage conditions (controlled temperature, protection from light) to maintain solution stability.

Hemosol B0 may interact with certain medications or clinical conditions; awareness of these interactions helps prevent complications during dialysis.

Avoid: - Concurrent administration of calcium‑containing intravenous drugs that could cause hypercalcemia. - Use with high‑dose bicarbonate or other strong alkalinizing agents that may exacerbate metabolic alkalosis.

Use with caution: - Loop diuretics, which can alter sodium and chloride balance during treatment. - Beta‑blockers, as they may mask signs of hypotension related to dialysis. - Anticoagulants (e.g., heparin) requiring close monitoring of clotting parameters.